{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:42:28Z","timestamp":1769560948895,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["837004009"],"award-info":[{"award-number":["837004009"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010763","name":"Zorginstituut Nederland","doi-asserted-by":"publisher","award":["837004009"],"award-info":[{"award-number":["837004009"]}],"id":[{"id":"10.13039\/501100010763","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Implantation of an implantable cardioverter defibrillator (ICD) is standard care for primary prevention of sudden cardiac death. However, ICD-related complications are increasing as the population of ICD recipients grows.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>ICD-related complications in a\u00a0national DO-IT Registry cohort of 1442 primary prevention ICD patients were assessed in terms of additional use of hospital care resources and costs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During a\u00a0median follow-up of 28.7\u00a0months (IQR 25.2\u201333.7) one or more complications occurred in 13.5% of patients. A\u00a0complication resulted in a\u00a0surgical intervention in 53% of cases and required on average 3.65 additional hospital days. The additional hospital costs were \u20ac6,876 per complication or \u20ac8,110 per patient, to which clinical re-interventions and additional hospital days contributed most. Per category of complications, infections required most hospital utilisation and were most expensive at an average of \u20ac22,892. The mean costs were \u20ac5,800 for lead-related complications, \u20ac2,291 for pocket-related complications and \u20ac5,619 for complications due to other causes. We estimate that the total yearly incidence-based costs in the Netherlands for hospital management of ICD-related complications following ICD implantation for primary prevention are \u20ac2.7\u00a0million.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Complications following ICD implantation are related to a\u00a0substantial additional need for hospital resources. When performing cost-effectiveness analyses of ICD implantation, including the costs associated with complications, one should be aware that real-world complication rates may deviate from trial data. Considering the economic implications, strategies to reduce the incidence of complications are encouraged.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12471-022-01733-4","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T17:57:34Z","timestamp":1669399054000},"page":"244-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hospital utilisation and the costs associated with complications of ICD implantation in a\u00a0contemporary primary prevention cohort"],"prefix":"10.1007","volume":"31","author":[{"given":"M.","family":"van Barreveld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. E.","family":"Verstraelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Buskens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. F. H. M.","family":"van Dessel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. V. A.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. P. H. M.","family":"Delnoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Tuinenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A. M. J.","family":"Theuns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. H.","family":"van der Voort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. P.","family":"Kimman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. H.","family":"Zwinderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A. M.","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G. W.","family":"Dijkgraaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"DO-IT investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"van Barreveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. E.","family":"Verstraelen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Buskens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. F. H. M.","family":"van Dessel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. V. A.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. P. H. M.","family":"Delnoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Tuinenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A. M. J.","family":"Theuns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. H.","family":"van der Voort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. P.","family":"Kimman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. H.","family":"Zwinderman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A. M.","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G. W.","family":"Dijkgraaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"1733_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy\u00a0GH, Lee\u00a0KL, Mark\u00a0DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N\u00a0Engl J Med. 2005;352:225\u201337.","journal-title":"N Engl J Med"},{"key":"1733_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa013474","volume":"346","author":"AJ Moss","year":"2002","unstructured":"Moss\u00a0AJ, Zareba\u00a0W, Hall\u00a0WJ, et\u00a0al. Prophylactic implantation of a\u00a0defibrillator in patients with myocardial infarction and reduced ejection fraction. N\u00a0Engl J Med. 2002;346:877\u201383.","journal-title":"N Engl J Med"},{"key":"1733_CR3","doi-asserted-by":"publisher","first-page":"e018063","DOI":"10.1161\/JAHA.120.018063","volume":"10","author":"M van Barreveld","year":"2021","unstructured":"van Barreveld\u00a0M, Verstraelen\u00a0TE, van Dessel\u00a0P, et al. Dutch outcome in implantable cardioverter-defibrillator therapy: implantable cardioverter-defibrillator-related complications in a\u00a0contemporary primary prevention cohort. J\u00a0Am Heart Assoc. 2021;10:e18063.","journal-title":"J Am Heart Assoc"},{"key":"1733_CR4","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.hrthm.2015.12.046","volume":"13","author":"MS Ascoeta","year":"2016","unstructured":"Ascoeta\u00a0MS, Marijon\u00a0E, Defaye\u00a0P, et al. Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention. Heart Rhythm. 2016;13:1045\u201351.","journal-title":"Heart Rhythm"},{"key":"1733_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/europace\/eun322","volume":"11","author":"GZ Duray","year":"2009","unstructured":"Duray\u00a0GZ, Schmitt\u00a0J, Cicek-Hartvig\u00a0S, Hohnloser\u00a0SH, Israel\u00a0CW. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices. Europace. 2009;11:297\u2013302.","journal-title":"Europace"},{"key":"1733_CR6","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/europace\/euv337","volume":"18","author":"V Exposito","year":"2016","unstructured":"Exposito\u00a0V, Rodriguez-Manero\u00a0M, Gonzalez-Enriquez\u00a0S, et al. Primary prevention implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator in elderly patients: results of a\u00a0Spanish multicentre study. Europace. 2016;18:1203\u201310.","journal-title":"Europace"},{"key":"1733_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/heartjnl-2017-311638","volume":"104","author":"NM Hawkins","year":"2018","unstructured":"Hawkins\u00a0NM, Grubisic\u00a0M, Andrade\u00a0JG, et al. Long-term complications, reoperations and survival following cardioverter-defibrillator implant. Heart. 2018;104:237\u201343.","journal-title":"Heart"},{"key":"1733_CR8","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/eurheartj\/eht511","volume":"35","author":"RE Kirkfeldt","year":"2014","unstructured":"Kirkfeldt\u00a0RE, Johansen\u00a0JB, Nohr\u00a0EA, Jorgensen\u00a0OD, Nielsen\u00a0JC. Complications after cardiac implantable electronic device implantations: an analysis of a\u00a0complete, nationwide cohort in Denmark. Eur Heart\u00a0J. 2014;35:1186\u201394.","journal-title":"Eur Heart J"},{"key":"1733_CR9","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1161\/CIRCULATIONAHA.110.015024","volume":"123","author":"M Landolina","year":"2011","unstructured":"Landolina\u00a0M, Gasparini\u00a0M, Lunati\u00a0M, et al. Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database. Circulation. 2011;123:2526\u201335.","journal-title":"Circulation"},{"key":"1733_CR10","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJMsa051989","volume":"353","author":"GD Sanders","year":"2005","unstructured":"Sanders\u00a0GD, Hlatky\u00a0MA, Owens\u00a0DK. Cost-effectiveness of implantable cardioverter-defibrillators. N\u00a0Engl J Med. 2005;353:1471\u201380.","journal-title":"N Engl J Med"},{"key":"1733_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ahj.2010.04.021","volume":"160","author":"GD Sanders","year":"2010","unstructured":"Sanders\u00a0GD, Kong\u00a0MH, Al-Khatib\u00a0SM, Peterson\u00a0ED. Cost-effectiveness of implantable cardioverter defibrillators in patients \u226565\u00a0years of age. Am Heart\u00a0J. 2010;160:122\u201331.","journal-title":"Am Heart J"},{"key":"1733_CR12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s10198-014-0637-x","volume":"16","author":"L Garcia-Perez","year":"2015","unstructured":"Garcia-Perez\u00a0L, Pinilla-Dominguez\u00a0P, Garcia-Quintana\u00a0A, et al. Economic evaluations of implantable cardioverter defibrillators: a\u00a0systematic review. Eur J Health Econ. 2015;16:879\u201393.","journal-title":"Eur J Health Econ"},{"key":"1733_CR13","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s12471-017-1016-x","volume":"25","author":"M van Barreveld","year":"2017","unstructured":"van Barreveld\u00a0M, Dijkgraaf\u00a0MGW, Hulleman\u00a0M, et al. Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a\u00a0prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator. Neth Heart\u00a0J. 2017;25:574\u201380.","journal-title":"Neth Heart J"},{"key":"1733_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/europace\/euab012","volume":"23","author":"TE Verstraelen","year":"2021","unstructured":"Verstraelen\u00a0TE, van Barreveld\u00a0M, van Dessel\u00a0P, et al. Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death. Europace. 2021;23:887\u201397.","journal-title":"Europace"},{"key":"1733_CR15","unstructured":"Amsterdam UMC Directorate Finance & Control. Unit costing sheet 2017; internal report. Amsterdam: Amsterdam UMC\u2014location AMC, 2018. Contact person: m.g.dijkgraaf@amsterdamumc.nl."},{"key":"1733_CR16","unstructured":"Hakkaart-van Roijen L, Van der Linden N, Bouwmans C, Kanters T, Tan SS. Kostenhandleiding. Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg In opdracht van Zorginstituut Nederland Geactualiseerde versie 2015:12\u201364. Available from: https:\/\/www.zorginstituutnederland.nl\/over-ons\/publicaties\/publicatie\/2016\/02\/29\/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg. Accessed March 2019"},{"key":"1733_CR17","unstructured":"National Cardiovascular Data Registry. Nationale rapportage 2015 & ACS Snapshotweken: nationale rapportage ICD procedures peildatum 15-10-2016. Utrecht: NCDR, 2016, page 34. In combination with www.opendisdata.nl, declaration code counts 33280, 22282, 33291, 33294 & 33298 under health care product codes 979001242 & 979001243 for the years 2013\u20132017."},{"key":"1733_CR18","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/jce.12438","volume":"25","author":"D Jamerson","year":"2014","unstructured":"Jamerson\u00a0D, McNitt\u00a0S, Polonsky\u00a0S, Zareba\u00a0W, Moss\u00a0A, Tompkins\u00a0C. Early procedure-related adverse events by gender in MADIT-CRT. J\u00a0Cardiovasc Electrophysiol. 2014;25:985\u20139.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1733_CR19","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1016\/j.jacc.2019.09.060","volume":"74","author":"DH Birnie","year":"2019","unstructured":"Birnie\u00a0DH, Wang\u00a0J, Alings\u00a0M, et\u00a0al. Risk factors for infections involving cardiac implanted electronic devices. J\u00a0Am Coll Cardiol. 2019;74:2845\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"1733_CR20","unstructured":"Organisation for Economic Co-operation and Development. Purchasing power parities. Available from: https:\/\/data.oecd.org\/conversion\/purchasing-power-parities-ppp.htm. Accessed March 2019"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-022-01733-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-022-01733-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-022-01733-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T13:27:57Z","timestamp":1684243677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-022-01733-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1733"],"URL":"https:\/\/doi.org\/10.1007\/s12471-022-01733-4","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"assertion":[{"value":"29 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.V.A.\u00a0Boersma reports grants from Boston Scientific and is a consultant to Boston Scientific and Medtronic, outside the scope of the submitted work. M.\u00a0van Barreveld, T.E.\u00a0Verstraelen, E.\u00a0Buskens, P.F.H.M.\u00a0van Dessel, P.P.H.M.\u00a0Delnoy, A.E.\u00a0Tuinenburg, D.A.M.J.\u00a0Theuns, P.H.\u00a0van der Voort, G.P.\u00a0Kimman, A.H.\u00a0Zwinderman, A.A.M.\u00a0Wilde and M.G.W.\u00a0Dijkgraaf declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}